Complementary Healthcare Analysis - 2019-08-07
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
Long/Short Equity, Healthcare, Biotech
Contributor Since 2017
Avisol Capital Partners runs the Total Pharma Tracker Seeking Alpha Marketplace service. This is managed by Dr Asok Dutta, BVScAH and Dr Udaya Kumar Maiya, MD Oncologist. The service offers end-to-end research on both investing and trading ideas everyday, and includes a 150-stock watchlist and two 40-stock model portfolios that are continuously tracked.
Dr Dutta is a retired veterinary surgeon. He has over 40 years experience in the industry. Dr Maiya is a well-known oncologist who has 30 years in the medical field, including as Medical Director of various healthcare institutions. Both doctors are also avid private investors. They are assisted by a number of finance professionals in developing this service.
If you want to check out our service, go here - https://seekingalpha.com/author/avisol-capital-partners/research
Disclaimer - we are not investment advisors.
Dr Dutta is a retired veterinary surgeon. He has over 40 years experience in the industry. Dr Maiya is a well-known oncologist who has 30 years in the medical field, including as Medical Director of various healthcare institutions. Both doctors are also avid private investors. They are assisted by a number of finance professionals in developing this service.
If you want to check out our service, go here - https://seekingalpha.com/author/avisol-capital-partners/research
Disclaimer - we are not investment advisors.
| Top Gainers | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Aurora Cannabis Inc. (ACB) | - | 6.83 | 10.34% | 36,803,512 | |
| Community Health Systems, Inc. (CYH) | 266.52M | 2.19 | 14.66% | 5,669,275 | |
| Zoetis Inc. (ZTS) | 58.11B | 121.17 | 7.64% | 4,042,312 | |
| Allakos Inc. (ALLK) | 3.59B | 79.47 | 21.77% | 3,952,570 | |
| HEXO Corp. (HEXO) | 781.97M | 4.41 | 5.25% | 3,948,948 | |
| Top Losers | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Teva Pharmaceutical Industries Limited (TEVA) | 7.94B | 7.06 | -9.83% | 47,555,836 | |
| Mylan N.V. (MYL) | 9.62B | 18.20 | -5.94% | 15,592,762 | |
| Mallinckrodt plc (MNK) | 477.72M | 5.70 | -12.04% | 13,280,957 | |
| Endo International plc (ENDP) | 520.90M | 2.25 | -21.05% | 12,696,200 | |
| ViewRay, Inc. (VRAY) | 689.82M | 6.97 | -5.94% | 2,729,086 | |
| High volume stocks reaching new highs | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Zoetis Inc. (ZTS) | 58.11B | 121.17 | 7.64% | 4,042,312 | |
| Allakos Inc. (ALLK) | 3.59B | 79.47 | 21.77% | 3,952,570 | |
| DURECT Corporation (DRRX) | 240.19M | 1.44 | 13.39% | 2,846,590 | |
| Insulet Corporation (PODD) | 8.66B | 143.13 | 21.37% | 2,519,748 | |
| Haemonetics Corporation (HAE) | 6.78B | 131.24 | 12.02% | 814,646 | |
| High volume stocks reaching new lows | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Teva Pharmaceutical Industries Limited (TEVA) | 7.94B | 7.06 | -9.83% | 47,555,836 | |
| Mallinckrodt plc (MNK) | 477.72M | 5.70 | -12.04% | 13,280,957 | |
| Endo International plc (ENDP) | 520.90M | 2.25 | -21.05% | 12,696,200 | |
| TherapeuticsMD, Inc. (TXMD) | 473.43M | 1.87 | -2.60% | 5,673,325 | |
| Amneal Pharmaceuticals, Inc. (AMRX) | 970.49M | 2.99 | -0.99% | 3,064,344 | |
| Major Analyst Upgrades | |||||
| Company | Current Rating | New Rating | Analyst | Current Price | Target Price |
| Insulet (PODD) | Neutral | Overweight | JPMorgan Chase & Co. | $143.13 | $155.00 |
| Major Analyst Downgrades | |||||
| Company | Current Rating | New Rating | Analyst | Current Price | Target Price |
| n/a | |||||
| Major Insider Buys | |||||
| Company | Insider Name | Insider Title | Price | Qty | Value |
| Ligand Pharmaceuticals Inc (LGND) | Aryeh Jason | Dir | $90.01 | 746 | +$67,146 |
| Exicure, Inc. (XCUR) | Mirkin Chad A. | Dir, 10% | $2.00 | 25000 | +$50,000 |
| Venkatesan Jay | Dir | $2.00 | 250000 | +$500,000 | |
| Walt David R | Dir | $2.00 | 1000000 | +$2,000,000 | |
| Vtv Therapeutics Inc. (VTVT) | Perelman Ronald O | 10% | $1.65 | 1212121 | +$2,000,000 |
| Major Insider Sells | |||||
| Company | Insider Name | Insider Title | Price | Qty | Value |
| Medicines Co /de (MDCO) | Rodin Stephen M | EVP, GC | $34.82 | -5000 | -$174,100 |
| Tyme Technologies, Inc. (TYME) | Demurjian Michael | 10% | $1.12 | -20000 | -$22,450 |
| Verrica Pharmaceuticals Inc. (VRCA) | Davidson Matt | 10% | $10.54 | -6250 | -$65,856 |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | Arbuckle Stuart A | EVP\Chief Commercial Officer | $177.22 | -3708 | -$657,127 |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | Parini Michael | EVP, CL, AO | $175.28 | -2330 | -$408,399 |
| Y-Mabs Therapeutics, Inc. (YMAB) | Gad Thomas | Pres, COB | $21.78 | -4000 | -$87,106 |
Index Watch
NASDAQ Health CareINDEXNASDAQ: IXHC
iShares NASDAQ Biotechnology Index
NASDAQ: IBB